⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

December 1, 2003PEDIATRICS

Revised Indications for the Use of Palivizumab and Respiratory Syncytial Virus Immune Globulin Intravenous for the Prevention of Respiratory Syncytial Virus Infections

View Full Paper

Ask AI

Bookmark

Share

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

A 2003 study studied this question.

synapsesocial.com/papers/6a8bd0d4039371f2a3896ab2 https://doi.org/10.1542/peds.112.6.1442

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

1Revised Indications for the Use of Palivizumab and Respiratory Syncytial Virus Immune Globulin Intravenous for the Prevention of Respiratory Syncytial Virus Infections2003 · 326 citations
2National Surveillance For Respiratory Syncytial Virus, United States, 1985-19901994 · 100 citations
3Prevention of Respiratory Syncytial Virus Infections: Indications for the Use of Palivizumab and Update on the Use of RSV-IGIV1998 · 414 citations
4Respiratory Syncytial Virus Immune Globulin Intravenous: Indications for Use1997 · 107 citations